Provided by Tiger Fintech (Singapore) Pte. Ltd.

Loews

98.83
+0.66000.67%
Post-market: 98.830.00000.00%18:35 EDT
Volume:665.63K
Turnover:65.66M
Market Cap:20.50B
PE:15.75
High:98.92
Open:98.37
Low:98.15
Close:98.17
52wk High:103.52
52wk Low:75.16
Shares:207.43M
Float Shares:170.15M
Volume Ratio:0.78
T/O Rate:0.39%
Dividend:0.25
Dividend Rate:0.25%
EPS(TTM):6.28
EPS(LYR):6.42
ROE:7.99%
ROA:1.66%
PB:1.17
PE(LYR):15.39

Loading ...

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

GlobeNewswire
·
Yesterday

Press Release: Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board

Dow Jones
·
Oct 16

Loews Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 16

US insurance composite advanced 0.6% last week as Wall Street defied shutdown

Reuters
·
Oct 07

Dino Robusto, Executive Chairman, Reports Disposal of CNA Financial Corporation Common Shares

Reuters
·
Oct 02

Beazley and Slide lead September gains in Europe and the US

Reuters
·
Oct 01

US insurance composite outperforms Wall Street as reinsurers rally after hurricanes shift offshore

Reuters
·
Sep 29

The biggest risk to Fed independence is a divided Congress - not Trump

Dow Jones
·
Sep 29

MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent

GlobeNewswire
·
Sep 24

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

GlobeNewswire
·
Sep 23

US insurance composite underperforms Wall Street, reinsurer shares lead losses

Reuters
·
Sep 22

Brain drain? How Wall Street is reacting to $100,000 charge for H1-B visas

Dow Jones
·
Sep 22

Form 8.5 (EPT/RI) - Treatt plc

GlobeNewswire
·
Sep 19

FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma

GlobeNewswire
·
Sep 16

AUO Unit OKs $50 Million Capital Reduction

MT Newswires Live
·
Sep 15

The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration

prnewswire
·
Sep 12

Loews Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 12

MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 11

Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)

GlobeNewswire
·
Sep 10

Lianson Fleet Unit to Acquire Vessel for About $7 Million in Cash

MT Newswires Live
·
Sep 09